About Ledviclear Ledipasvir 90 mg and Sofosbuvir 400 mg Tablets
Contents: Ledipasvir 90mg and Sofosbuvir 400mg
Manufactured by: Abbott
Packing: Pack of 28 Tablets
WHAT IS LEDVICLEAR TABLETS?
Ledviclear contains a combination of Ledipasvir 90mg and Sofosbuvir 400mg. Ledipasvir and sofosbuvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.
WHAT IS THE PRESCRIBED USE OF LEDVICLEAR TABLETS?
Ledviclear is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication. These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
WHAT ARE THE POSSIBLE SIDE-EFFECTS OF LEDVICLEAR TABLETS?
Tiredness, headache, nausea, diarrhea, or difficulty sleeping may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.
WHAT IS THE IMPORTANT SAFETY INFORMATION OF LEDVICLEAR TABLETS?
You should not use Ledviclear if you are allergic to Ledipasvir or Sofosbuvir.
To make sure Ledviclear is safe for you, tell your doctor if you have a history of hepatitis B; liver problems other than hepatitis; a history of liver transplant; kidney disease (or if you are on dialysis); HIV or AIDS.
Dual Active Ingredients for Enhanced EfficacyEach tablet contains a precise blend of Ledipasvir 90 mg and Sofosbuvir 400 mg, formulated to target the Hepatitis C virus effectively. Both components work synergistically to inhibit virus replication, offering a higher chance of achieving a sustained virologic response and improving patient outcomes.
Guidelines for Safe Storage and HandlingLedviclear tablets require storage below 30C (86F) in a cool, dry environment that is protected from direct light. Refrigeration is recommended when needed, and improper storage can compromise both the effectiveness and the shelf life of the medication. Always keep the product tightly closed and away from moisture.
FAQ's of Ledviclear Ledipasvir 90 mg and Sofosbuvir 400 mg Tablets:
Q: How should Ledviclear tablets be taken for Hepatitis C?
A: Ledviclear tablets should be taken as directed by your healthcare provider. Follow your physician's dosage guidelines carefully, typically one tablet daily, with or without food, for the prescribed duration.
Q: What are the benefits of using Ledviclear for Hepatitis C treatment?
A: Ledviclear combines Ledipasvir and Sofosbuvir, both of which directly inhibit the Hepatitis C virus. This results in a higher cure rate, improved liver function, and a lower risk of disease progression when taken as recommended.
Q: When should I store Ledviclear in the refrigerator?
A: Generally, Ledviclear should be kept below 30C in a cool, dry place. Only refrigerate if advised by your pharmacist or if room temperatures become excessively high, ensuring the medicine remains effective.
Q: Where is Ledviclear manufactured and distributed from?
A: Ledviclear is manufactured, supplied, and exported from India by certified pharmaceutical companies specializing in anti-viral treatments. It is available globally through authorized distributors and suppliers.
Q: What is the active ingredient composition of Ledviclear tablets?
A: Each tablet consists of Ledipasvir 90 mg and Sofosbuvir 400 mg as active antiviral ingredients, formulated specifically for the treatment of Hepatitis C.
Q: Who should use Ledviclear and are there any usage guidelines?
A: Ledviclear is intended for adults diagnosed with Hepatitis C, as prescribed by a physician. The usage and dosage should always follow medical advice, with regular follow-ups to monitor effectiveness and address potential side effects.